Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Rodeghiero

Showing results (111-120 of 266) with videos related to

Pageof 27
Sort By:
Thrombosis and Haemostasis|November 1, 2000
Grossly abnormal proteolysis of von Willebrand factor (VWF) in a patient heterozygous for a gene deletion and mutation in the dimerization area of VWFG Castaman, J C Eikenboom, A Lattuada, et al.
American Journal of Hematology|May 1, 1993
Desmopressin-induced thrombocytopenia in type I platelet discordant von Willebrand diseaseG Castaman, F Rodeghiero, A Lattuada, et al.
Haematologica|September 1, 1993
Acute renal failure after high-dose intravenous immune globulin in a patient with idiopathic thrombocytopenic purpuraM Ruggeri, G Castaman, G De Nardi, et al.
British Journal of Haematology|March 1, 1997
Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generationG Castaman, L Yu-Feng, E Battistin, et al.
American Journal of Hematology|January 1, 1991
Clinical pharmacokinetics of a placenta-derived factor XIII concentrate in type I and type II factor XIII deficiencyF Rodeghiero, A Tosetto, E Di Bona, et al.
Thrombosis Research|February 1, 1992
A new variant of von Willebrand disease (type II I) with a normal degree of proteolytic cleavage of von Willebrand factorG Castaman, F Rodeghiero, A Lattuada, et al.
Thrombosis and Haemostasis|August 26, 2000
Pregnancy in women with type 1 von Willebrand disease caused by heterozygosity for von Willebrand factor mutation C1130FG Castaman, J C Eikenboom, A Contri, et al.
Thrombosis Research|August 15, 1994
Parallel line bioassay or single-point calibration for the establishment of reference rangesA Tosetto, E Gatto, M T Masiero, et al.
American Journal of Hematology|May 1, 1995
Characterization of two cases of acquired transitory von Willebrand syndrome with ciprofloxacin: evidence for heightened proteolysis of von Willebrand factorG Castaman, A Lattuada, P M Mannucci, et al.
Blood|November 1, 1989
Consistency of responses to repeated DDAVP infusions in patients with von Willebrand's disease and hemophilia AF Rodeghiero, G Castaman, E Di Bona, et al.
Pageof 27

Showing results (111-120 of 266) with videos related to

Sort By:
Pageof 27
Thrombosis and Haemostasis|November 1, 2000
Grossly abnormal proteolysis of von Willebrand factor (VWF) in a patient heterozygous for a gene deletion and mutation in the dimerization area of VWFG Castaman, J C Eikenboom, A Lattuada, et al.
American Journal of Hematology|May 1, 1993
Desmopressin-induced thrombocytopenia in type I platelet discordant von Willebrand diseaseG Castaman, F Rodeghiero, A Lattuada, et al.
Haematologica|September 1, 1993
Acute renal failure after high-dose intravenous immune globulin in a patient with idiopathic thrombocytopenic purpuraM Ruggeri, G Castaman, G De Nardi, et al.
British Journal of Haematology|March 1, 1997
Characterization of a novel bleeding disorder with isolated prolonged bleeding time and deficiency of platelet microvesicle generationG Castaman, L Yu-Feng, E Battistin, et al.
American Journal of Hematology|January 1, 1991
Clinical pharmacokinetics of a placenta-derived factor XIII concentrate in type I and type II factor XIII deficiencyF Rodeghiero, A Tosetto, E Di Bona, et al.
Thrombosis Research|February 1, 1992
A new variant of von Willebrand disease (type II I) with a normal degree of proteolytic cleavage of von Willebrand factorG Castaman, F Rodeghiero, A Lattuada, et al.
Thrombosis and Haemostasis|August 26, 2000
Pregnancy in women with type 1 von Willebrand disease caused by heterozygosity for von Willebrand factor mutation C1130FG Castaman, J C Eikenboom, A Contri, et al.
Thrombosis Research|August 15, 1994
Parallel line bioassay or single-point calibration for the establishment of reference rangesA Tosetto, E Gatto, M T Masiero, et al.
American Journal of Hematology|May 1, 1995
Characterization of two cases of acquired transitory von Willebrand syndrome with ciprofloxacin: evidence for heightened proteolysis of von Willebrand factorG Castaman, A Lattuada, P M Mannucci, et al.
Blood|November 1, 1989
Consistency of responses to repeated DDAVP infusions in patients with von Willebrand's disease and hemophilia AF Rodeghiero, G Castaman, E Di Bona, et al.
Pageof 27